Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Unorthodox Ventures is a venture capital firm founded in 2020 and headquartered in Austin, Texas. The firm has additional offices in New York and Tel Aviv, allowing it to maintain a global presence. Unorthodox Ventures focuses on early-stage investments, particularly in the medical technology and construction technology sectors. The firm has built a portfolio of 30 companies, demonstrating its commitment to supporting innovative solutions that address critical challenges in these industries.
Since its inception, Unorthodox Ventures has aimed to assist European and Israeli companies in entering the U.S. market, providing them with the necessary resources and strategic support. The firm prioritizes long-term success over short-term gains, aligning its investment strategy with sustainable growth. Notable milestones include the successful funding of companies that have developed groundbreaking technologies in their respective fields.
Unorthodox Ventures primarily invests in the medical technology sector, with a specific emphasis on cardiology and gastrointestinal treatments. Additionally, the firm is active in the construction technology space, focusing on innovations that enhance job-site productivity. The organization typically engages in seed and Series A funding rounds, with investment sizes ranging from $1 million to $5 million. This range allows them to support early-stage companies effectively while maintaining a significant stake in their growth.
The firm also plays a crucial role in helping European and Israeli startups navigate the complexities of entering the U.S. market. Unorthodox Ventures looks for founders who demonstrate a strong vision and the ability to execute their ideas. Their investment strategy is designed to foster long-term success, ensuring that portfolio companies are well-positioned for sustainable growth in competitive markets.
Unorthodox Ventures has built a diverse portfolio of 30 companies, focusing on innovative solutions in healthcare and construction technology. Notable portfolio companies include:
Carey Smith: Founding Contrarian with a background in venture capital and entrepreneurship, known for leading innovative investment strategies.
Yechiel (Ben) Lanzkron: Experienced in healthcare investments, focusing on medical technology startups.
Lewis Kilongo: Specializes in construction technology, bringing expertise in operational efficiency.
Cuinn Alexander: Focuses on market entry strategies for international startups.
Daniel Allen: Has a strong background in financial analysis and investment management.
Rachel Nelson: Engaged in business development and strategic partnerships.
Steven Levy: Experienced in healthcare technology and innovation.
Isaac Weiss: Focuses on operational support for portfolio companies.
Brian Smith: Specializes in consumer product investments.
Dan Easton: Experienced in venture capital and startup growth strategies.
David Banks: Focuses on market analysis and investment strategy.
Gavin Holiday: Engaged in technology scouting and investment sourcing.
Tristan Smith: Specializes in health and wellness investments.
Adam Kahn: Focuses on operational efficiency in portfolio companies.
Scott Sloan: Experienced in venture capital and startup mentorship.
To pitch to Unorthodox Ventures, founders should use the investment inquiry form available on their website. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. The firm typically responds within a few weeks, and warm introductions are preferred but not mandatory.
As of March 2023, Unorthodox Ventures continues to expand its portfolio, focusing on innovative companies in healthcare and construction technology. The firm has recently made investments in several early-stage startups, although specific details on these investments have not been disclosed.
Unorthodox Ventures remains active in supporting its portfolio companies, particularly those looking to enter the U.S. market. The firm is also exploring new opportunities for collaboration with European and Israeli startups.
What are Unorthodox Ventures' investment criteria?
Unorthodox Ventures invests in early-stage companies primarily in the medical technology and construction technology sectors. They focus on seed and Series A funding rounds, typically investing between $1 million and $5 million.
How can I apply or pitch to Unorthodox Ventures?
Founders can pitch their ideas through the investment inquiry form available on their website. It is recommended to include a detailed business plan and financial projections in the pitch deck.
What makes Unorthodox Ventures different from other firms?
The firm emphasizes long-term success over short-term gains, providing strategic support to portfolio companies, particularly in navigating the U.S. market. Their focus on healthcare and construction technology sets them apart in the venture capital landscape.
What is the geographic scope of Unorthodox Ventures?
Unorthodox Ventures invests in companies located in North America, Europe, and Asia, with a particular focus on assisting European and Israeli startups in entering the U.S. market.
What is the firm's post-investment involvement like?
Unorthodox Ventures provides ongoing support to its portfolio companies, helping them scale operations and navigate market challenges. This includes strategic guidance and access to their network.
What is the typical check size for investments?
The firm typically invests between $1 million and $5 million in each funding round, allowing them to take significant stakes in their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.